Stockreport

Repligen Corporation (RGEN) Benefitted From Drug Approval [Yahoo! Finance]

Repligen Corporation  (RGEN) 
Last repligen corporation earnings: 2/20 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: repligen.com/investors
PDF A copy of the letter can be downloaded here . In the second quarter, the fund (Institutional Shares) declined 7.78% underperforming the 2.92% return for the Russell 2000 [Read more]